[go: up one dir, main page]

DE2626095A1 - Verfahren zur herstellung von estern von alpha-methyl-3,4-dihydroxyphenylalanin - Google Patents

Verfahren zur herstellung von estern von alpha-methyl-3,4-dihydroxyphenylalanin

Info

Publication number
DE2626095A1
DE2626095A1 DE19762626095 DE2626095A DE2626095A1 DE 2626095 A1 DE2626095 A1 DE 2626095A1 DE 19762626095 DE19762626095 DE 19762626095 DE 2626095 A DE2626095 A DE 2626095A DE 2626095 A1 DE2626095 A1 DE 2626095A1
Authority
DE
Germany
Prior art keywords
general formula
hydrogen atom
tert
group
represent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19762626095
Other languages
German (de)
English (en)
Inventor
Ralph Franz Hirschmann
Burwell Frederick Powell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2626095A1 publication Critical patent/DE2626095A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19762626095 1975-06-11 1976-06-10 Verfahren zur herstellung von estern von alpha-methyl-3,4-dihydroxyphenylalanin Pending DE2626095A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58600775A 1975-06-11 1975-06-11

Publications (1)

Publication Number Publication Date
DE2626095A1 true DE2626095A1 (de) 1976-12-30

Family

ID=24343905

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762626095 Pending DE2626095A1 (de) 1975-06-11 1976-06-10 Verfahren zur herstellung von estern von alpha-methyl-3,4-dihydroxyphenylalanin

Country Status (7)

Country Link
JP (1) JPS51149241A (da)
DE (1) DE2626095A1 (da)
DK (1) DK229876A (da)
FR (1) FR2313922A1 (da)
GB (1) GB1518745A (da)
NL (1) NL7605698A (da)
SE (1) SE7605911L (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57112385A (en) * 1980-12-29 1982-07-13 Suntory Ltd Production of mugineic acids
US4440942A (en) * 1982-03-01 1984-04-03 Merck & Co., Inc. Crystalline diastereomeric L-alpha-methyldopa POE ester and process for its preparation
LU85757A1 (fr) * 1985-02-04 1986-09-02 Univ Catholique Louvain Derives nouveaux de la l-dopa,procedes pour leur preparation et compositions pharmaceutiques concernant de tels composes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983138A (en) * 1973-09-25 1976-09-28 Merck & Co., Inc. Amino acid esters

Also Published As

Publication number Publication date
DK229876A (da) 1976-12-12
NL7605698A (nl) 1976-12-14
FR2313922A1 (fr) 1977-01-07
SE7605911L (sv) 1976-12-12
JPS51149241A (en) 1976-12-22
FR2313922B1 (da) 1979-09-21
GB1518745A (en) 1978-07-26

Similar Documents

Publication Publication Date Title
DE60030883T2 (de) Verfahren zur herstellung von alfentanil, sufentanil und remifentanil
EP0153277B1 (de) Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DD127966B3 (de) Verfahren zur herstellung von pyrrolidinderivaten
CH623571A5 (da)
WO1985002847A1 (fr) Esters et amides d'acides carboniques carbocycliques et heterocycliques d'amines ou d'alcools azotes cycliques portes et non portes
DE69120899T2 (de) Neue N-Benzoylprolin-Derivate, Verfahren zur Herstellung und diese enthaltende Arzneimittel
DE2712023A1 (de) Sulfonamidoaminobenzoesaeurederivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
DE2047658A1 (da)
DE1545925A1 (de) Neue Pyrrolidinderivate und Verfahren zur Herstellung derselben
DE2437487A1 (de) 7-methoxy-6-thia-tetracycline und verfahren zu ihrer herstellung
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE1445904A1 (de) Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
DD284875A5 (de) Verfahren zur herstellung von 1-[(diarylmethoxy)-alkyl]-pyrrolidinen und -piperidinen
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2514673C2 (de) Benzo[b]bicyclo[3.3.1]nona-3,6a(10a)diene, Verfahren zu ihrer Herstellung und diese enthaltende anorektische Mittel
DE2626095A1 (de) Verfahren zur herstellung von estern von alpha-methyl-3,4-dihydroxyphenylalanin
DD142545A5 (de) Verfahren zur herstellung neuer omega thiobutyramide
DE1001261C2 (de) Verfahren zur Herstellung von basischen Estern endocyclisch substituierter Mandelsaeuren und ihren Salzen
DE2305514A1 (de) Verfahren zur herstellung von lysergsaeureamiden und dihydrolysergsaeureamiden sowie lysergsaeureamide und dihydrolysergsaeureamide und ihre verwendung
DE3642497A1 (de) Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
EP1607090A1 (de) Asimadolin für die Behandlung des Irritable Bowel Syndroms
AT265256B (de) Verfahren zur Herstellung neuer 2-Aryltetrahydropyran-3-amine und ihrer Salze
DE3028064C2 (da)
DE2528194C2 (de) Benzhydryloxyäthylamin-Derivate, deren Salze, Verfahren zur Herstellung derselben und solche enthaltende Arzneimittel
DD253616A5 (de) Verfahren zur herstellung von neuen pleunromutilinderivaten

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee